For help on how to get the results you want, see our search tips.
1349 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Orphan designations Remove Orphan designations filter
Withdrawn applications Remove Withdrawn applications filter
Categories
Human Remove Human filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Prometax (updated)
rivastigmine, Alzheimer Disease; Parkinson Disease; Dementia
Date of authorisation: 03/12/1998, Revision: 45, Authorised, Last updated: 08/06/2023 -
List item
Human medicine European public assessment report (EPAR): Exelon (updated)
rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 11/05/1998, Revision: 46, Authorised, Last updated: 08/06/2023 -
List item
Human medicine European public assessment report (EPAR): Evrenzo (updated)
Roxadustat, Anemia; Kidney Failure, Chronic
Date of authorisation: 18/08/2021,
, Revision: 3, Authorised, Last updated: 08/06/2023
-
List item
Human medicine European public assessment report (EPAR): Rekambys (updated)
rilpivirine, HIV Infections
Date of authorisation: 17/12/2020,, Revision: 8, Authorised, Last updated: 08/06/2023
-
List item
Human medicine European public assessment report (EPAR): Tenkasi (previously Orbactiv) (updated)
oritavancin diphosphate, Soft Tissue Infections; Skin Diseases, Bacterial
Date of authorisation: 19/03/2015, Revision: 12, Authorised, Last updated: 08/06/2023 -
List item
Human medicine European public assessment report (EPAR): Ryeqo (updated)
relugolix, norethisterone acetate, estradiol hemihydrate, Leiomyoma
Date of authorisation: 16/07/2021,, Revision: 5, Authorised, Last updated: 08/06/2023
-
List item
Human medicine European public assessment report (EPAR): Amversio (updated)
betaine, Homocystinuria
Date of authorisation: 05/05/2022,
, Authorised, Last updated: 08/06/2023
-
List item
Human medicine European public assessment report (EPAR): Omvoh (updated)
Mirikizumab, Colitis, Ulcerative
Date of authorisation: 26/05/2023,, Authorised, Last updated: 08/06/2023
-
List item
Human medicine European public assessment report (EPAR): Zonisamide Mylan (updated)
zonisamide, Epilepsy
Date of authorisation: 31/03/2016,, Revision: 9, Authorised, Last updated: 08/06/2023
-
List item
Human medicine European public assessment report (EPAR): Jentadueto (updated)
linagliptin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 19/07/2012, Revision: 21, Authorised, Last updated: 07/06/2023 -
List item
Human medicine European public assessment report (EPAR): Lutetium (177Lu) chloride Billev (previously Illuzyce) (updated)
lutetium (177Lu) chloride, Radionuclide Imaging
Date of authorisation: 15/09/2022, Revision: 2, Authorised, Last updated: 07/06/2023 -
List item
Human medicine European public assessment report (EPAR): Synjardy (updated)
empagliflozin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 27/05/2015, Revision: 25, Authorised, Last updated: 07/06/2023 -
List item
Human medicine European public assessment report (EPAR): Kaftrio (updated)
ivacaftor, tezacaftor, elexacaftor, Cystic Fibrosis
Date of authorisation: 21/08/2020,, 
, Revision: 12, Authorised, Last updated: 07/06/2023
-
List item
Human medicine European public assessment report (EPAR): Myozyme (updated)
alglucosidase alfa, Glycogen Storage Disease Type II
Date of authorisation: 28/03/2006, Revision: 25, Authorised, Last updated: 07/06/2023 -
List item
Human medicine European public assessment report (EPAR): Atazanavir Krka (updated)
atazanavir (as sulfate), HIV Infections
Date of authorisation: 25/03/2019,, Revision: 2, Authorised, Last updated: 07/06/2023
-
List item
Human medicine European public assessment report (EPAR): Segluromet (updated)
ertugliflozin l-pyroglutamic acid, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 23/03/2018, Revision: 7, Authorised, Last updated: 07/06/2023 -
List item
Human medicine European public assessment report (EPAR): Ibrance (updated)
Palbociclib, Breast Neoplasms
Date of authorisation: 09/11/2016,, Revision: 16, Authorised, Last updated: 06/06/2023
-
List item
Human medicine European public assessment report (EPAR): Tobi Podhaler (updated)
Tobramycin, Cystic Fibrosis; Respiratory Tract Infections
Date of authorisation: 20/07/2011,, Revision: 20, Authorised, Last updated: 05/06/2023
-
List item
Human medicine European public assessment report (EPAR): SonoVue (updated)
sulphur hexafluoride, Ultrasonography; Echocardiography
Date of authorisation: 26/03/2001, Revision: 20, Authorised, Last updated: 05/06/2023 -
List item
Human medicine European public assessment report (EPAR): Tezspire (updated)
tezepelumab, Asthma
Date of authorisation: 19/09/2022,, Revision: 4, Authorised, Last updated: 05/06/2023
-
List item
Human medicine European public assessment report (EPAR): Vydura (updated)
Rimegepant, Migraine Disorders
Date of authorisation: 25/04/2022,, Revision: 5, Authorised, Last updated: 05/06/2023
-
List item
Human medicine European public assessment report (EPAR): Xerava (updated)
eravacycline, Infection; Bacterial Infections
Date of authorisation: 20/09/2018,, Revision: 7, Authorised, Last updated: 05/06/2023
-
List item
Human medicine European public assessment report (EPAR): Lacosamide Adroiq (updated)
lacosamide, Epilepsy
Date of authorisation: 31/05/2023,, Authorised, Last updated: 05/06/2023
-
List item
Human medicine European public assessment report (EPAR): Onpattro (updated)
patisiran sodium, Amyloidosis, Familial
Date of authorisation: 27/08/2018,, 
, , Revision: 11, Authorised, Last updated: 02/06/2023
-
List item
Human medicine European public assessment report (EPAR): Adynovi (updated)
rurioctocog alfa pegol, Hemophilia A
Date of authorisation: 08/01/2018,, Revision: 9, Authorised, Last updated: 02/06/2023